|
2020
|
Invention
|
Method for preparing tricyclic compound, and intermediate thereof. Disclosed in the present appli... |
|
2019
|
Invention
|
Compound acting as antibiotics. The present invention provides a novel antibiotic compound repres... |
|
|
Invention
|
Compound acting as antibiotics. Provided are a new antimicrobial agent compound as shown in the f... |
|
2017
|
Invention
|
Pharmaceutical composition comprising mineralocorticoid receptor antagonist and use thereof. Prov... |
|
|
Invention
|
Crystal forms of a 9-aminomethyl substituted tetracycline compound and a preparation method there... |
|
|
Invention
|
Crystal form of 9-aminomethyl substituted tetracycline compounds and preparation method therefor.... |
|
2014
|
Invention
|
Jnk inhibitors. The present invention belongs to the field of pharmaceutical techniques, and in p... |
|
2013
|
Invention
|
Crystal form of compound used as mineralocorticoid receptor antagonist and preparation method the... |
|
|
Invention
|
Bicyclic compound functioning as tyrosine kinase inhibitor. The present invention relates to a co... |
|
|
Invention
|
Indolinone derivative as tyrosine kinase inhibitor. The present invention relates to a compound r... |
|
|
Invention
|
Indole full ketone derivative used as tyrosine-kinase inhibitor. The present invention relates to... |
|
|
Invention
|
Pyrimidineamide derivative and preparation method and use thereof. Provided are a pyrimidineamide... |
|
|
Invention
|
Nitrogen-containing heteroaromatic ring derivative as tyrosine kinase inhibitor. The present inve... |
|
|
Invention
|
Pi3kδ inhibitor. Disclosed are a PI3Kδ inhibitor compound of formula (I), pharmaceutically accept... |
|
2012
|
Invention
|
Nitrogen-containing fused ring compounds as crth2 antagonists. 3, A, B are as defined in the desc... |
|
|
Invention
|
Nitrogen-containing fused ring compounds as crth2 antagonists. Nitrogen-containing fused ring com... |
|
|
Invention
|
Nitrogen-containing fused ring compounds for use as crth2 antagonists. Nitrogen-containing fused ... |
|
|
Invention
|
9-aminomethyl substituted tetracycline compounds. The present invention relates to a 9-aminomethy... |
|
|
Invention
|
Tigecycline derivative. The invention belongs to the medicinal technical field, and in particular... |
|
|
Invention
|
9-aminomethyl substituted tetracycline compound. The present invention relates to a 9-aminomethyl... |
|
|
Invention
|
Spiro-containing dihydropyrazole compounds. Provided are compounds of formula (I), pharmaceutical... |
|
2011
|
Invention
|
Dihydropyrazole compounds. Provided are a dihydropyrazole compound as represented by general form... |
|
|
Invention
|
Fused ring compound for use as mineralocorticoid receptor antagonist. The present invention belon... |
|
|
Invention
|
Oral carbapenem compounds containing aminosulfonyl azetidinyl. Disclosed are oral carbapenem comp... |
|
|
Invention
|
Oxazolidinone compounds containing ring-fused bicyclic ring, preparation method and use thereof. ... |
|
2010
|
Invention
|
Cephalosporin derivatives containing substituted nitrogen-containing fused heterocyclic ring. Com... |
|
2008
|
Invention
|
Sulfonyl-substituted carbapenem compounds.
The present invention relates to a compound of the fo... |
|
|
Invention
|
Sulfonyl-substituted carbapenem compounds. The invention provides a compound represented by formu... |
|
|
Invention
|
1&bgr;- methylcarbapenem antibiotics,the pharmaceutical composition and use thereof. Antibiotic 1... |
|
|
Invention
|
Novel carbapenem derivatives. Novel carbapenem derivatives, which belong to pharmaceutical art. I... |
